SCHEDULE 13GFiled Mar 12, 8:00 PM ET
AN2 Therapeutics, Inc. SCHEDULE 13G
Vivo Opportunity Fund Holdings, L.P.Summary not available
This filing does not have a generated research summary. You can still open the original filing and its exhibits.
This filing does not have a generated research summary. You can still open the original filing and its exhibits.